The effects of globalisation on the pharmaceutical industry in emerging markets: the case of Turkey

M. Cagri Pehlivanoglu

International Journal of Trade and Global Markets, 2010, vol. 3, issue 3, 231-246

Abstract: Foreign Direct Investment (FDI) has become the most important determinant in the process of globalisation, and as such, it is changing the economies of many countries. The main objective of this research is to investigate the nature of FDI inflows into the Turkish pharmaceutical industry and examine whether local or multinational firms drive the changing market. The paper indicates that when considering FDI, potential benefits must be weighed against potential costs. It is recommended that countries be cautious about maintaining local producers while involving multinationals in their industries.

Keywords: globalisation; FDI; foreign direct investment; pharmaceutical industry; Turkey; emerging markets; local firms; multinational corporations; MNCs. (search for similar items in EconPapers)
Date: 2010
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.inderscience.com/link.php?id=34872 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ids:ijtrgm:v:3:y:2010:i:3:p:231-246

Access Statistics for this article

More articles in International Journal of Trade and Global Markets from Inderscience Enterprises Ltd
Bibliographic data for series maintained by Sarah Parker ().